Differential modulation of the sGC-cGMP pathway by sGC stimulators and activators in human lung cells

Paula Montero1, María Amparo Bayarri2, Inés Roger3

  • 1Department of Pharmacology, Faculty of Medicine, University of Valencia 46010 Valencia, Spain; Research Foundation of the General University Hospital of Valencia (FIHGUV), 46014 Valencia, Spain; Biomedical Research Networking Centre on Respiratory Diseases (CIBERES), Health Institute Carlos III, 28029 Madrid, Spain.

PubMed

Insights

Soluble guanylate cyclase (sGC) activators, unlike stimulators, maintain cyclic GMP (cGMP) production under oxidative stress in lung cells. Combining activators with PDE5 inhibitors shows promise for treating chronic lung diseases.

Area of Science:

  • Pulmonary Medicine
  • Pharmacology
  • Cell Biology

Background:

  • Chronic lung diseases involve oxidative stress, inflammation, and fibrosis, impairing nitric oxide-soluble guanylate cyclase-cyclic GMP (NO-sGC-cGMP) signaling.
  • Reduced sGC α1 and β1 expression is observed in COPD and asthma patients.
  • Cigarette smoke extract (CSE) causes oxidative damage to sGC, reducing its responsiveness.

Purpose of the Study:

  • To investigate the differential effects of an sGC stimulator (riociguat) and an sGC activator (cinaciguat) on pulmonary cells.
  • To evaluate the impact of combining these agents with a PDE5 inhibitor (sildenafil).
  • To assess their efficacy in mitigating CSE-induced cellular damage and dysfunction.

Main Methods:

  • Primary human pulmonary cells (epithelial cells, fibroblasts, neutrophils, endothelial monolayers) were exposed to CSE.
  • Cells were treated with riociguat, cinaciguat, sildenafil, or combinations thereof.
  • cGMP production, sGC heme oxidation, oxidative stress markers, inflammatory cell adhesion, and profibrotic gene expression were measured.

Main Results:

  • CSE oxidized the sGC heme group, diminishing responsiveness to NO and riociguat.
  • Cinaciguat, but not riociguat, preserved cGMP production under oxidizing conditions.
  • Co-treatment with sildenafil enhanced cGMP levels for both drugs.
  • Both drugs attenuated CSE-induced oxidative stress, inflammation, and fibrosis; cinaciguat with sildenafil showed more potent effects.

Conclusions:

  • sGC activators exhibit distinct pharmacodynamic profiles compared to stimulators under oxidative conditions.
  • Cinaciguat, especially combined with sildenafil, demonstrates robust therapeutic potential.
  • sGC modulation represents a promising strategy for treating oxidative chronic lung diseases.

Related Concept Videos

GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.9K
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
12.0K
GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
10.2K
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.5K
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
9.2K
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
6.5K